Annual CFO
-$31.50 M
+$43.35 M+57.91%
31 December 2023
Summary:
Finch Therapeutics annual cash flow from operations is currently -$31.50 million, with the most recent change of +$43.35 million (+57.91%) on 31 December 2023. During the last 3 years, it has fallen by -$176.00 thousand (-0.56%). FNCH annual CFO is now -81.90% below its all-time high of -$17.32 million, reached on 31 December 2019.FNCH Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$4.73 M
-$364.00 K-8.34%
30 June 2024
Summary:
Finch Therapeutics quarterly cash flow from operations is currently -$4.73 million, with the most recent change of -$364.00 thousand (-8.34%) on 30 June 2024. Over the past year, it has increased by +$535.00 thousand (+10.17%). FNCH quarterly CFO is now -27.52% below its all-time high of -$3.71 million, reached on 31 December 2023.FNCH Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$18.05 M
+$4.43 M+19.71%
30 June 2024
Summary:
Finch Therapeutics TTM cash flow from operations is currently -$18.05 million, with the most recent change of +$4.43 million (+19.71%) on 30 June 2024. Over the past year, it has increased by +$24.02 million (+57.08%). FNCH TTM CFO is now -202.38% below its all-time high of -$5.97 million, reached on 31 March 2020.FNCH TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FNCH Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +57.9% | +10.2% | +57.1% |
| 3 y3 years | -0.6% | +67.1% | +71.6% |
| 5 y5 years | - | - | - |
FNCH Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -0.6% | +57.9% | -27.5% | +81.6% | at high | +76.7% |
| 5 y | 5 years | -81.9% | +57.9% | -27.5% | +81.6% | -202.4% | +76.7% |
| alltime | all time | -81.9% | +57.9% | -27.5% | +81.6% | -202.4% | +76.7% |
Finch Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$4.73 M(+8.3%) | -$18.05 M(-19.7%) |
| Mar 2024 | - | -$4.36 M(+17.7%) | -$22.49 M(-28.6%) |
| Dec 2023 | -$31.50 M(-57.9%) | -$3.71 M(-29.6%) | -$31.50 M(-25.1%) |
| Sept 2023 | - | -$5.26 M(-42.5%) | -$42.07 M(-24.7%) |
| June 2023 | - | -$9.16 M(-31.6%) | -$55.90 M(-10.7%) |
| Mar 2023 | - | -$13.38 M(-6.2%) | -$62.59 M(-16.4%) |
| Dec 2022 | -$74.85 M | -$14.27 M(-25.3%) | -$74.85 M(+0.7%) |
| Sept 2022 | - | -$19.09 M(+20.6%) | -$74.37 M(+6.8%) |
| June 2022 | - | -$15.84 M(-38.2%) | -$69.62 M(-10.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$25.65 M(+86.0%) | -$77.56 M(+15.5%) |
| Dec 2021 | -$67.13 M(+114.3%) | -$13.79 M(-3.9%) | -$67.13 M(+5.5%) |
| Sept 2021 | - | -$14.35 M(-39.7%) | -$63.63 M(+13.2%) |
| June 2021 | - | -$23.78 M(+56.3%) | -$56.19 M(+38.5%) |
| Mar 2021 | - | -$15.21 M(+48.0%) | -$40.57 M(+29.5%) |
| Dec 2020 | -$31.33 M(+80.9%) | -$10.28 M(+48.7%) | -$31.33 M(+48.9%) |
| Sept 2020 | - | -$6.91 M(-15.3%) | -$21.05 M(+48.9%) |
| June 2020 | - | -$8.16 M(+36.7%) | -$14.13 M(+136.7%) |
| Mar 2020 | - | -$5.97 M | -$5.97 M |
| Dec 2019 | -$17.32 M | - | - |
FAQ
- What is Finch Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Finch Therapeutics?
- What is Finch Therapeutics annual CFO year-on-year change?
- What is Finch Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Finch Therapeutics?
- What is Finch Therapeutics quarterly CFO year-on-year change?
- What is Finch Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Finch Therapeutics?
- What is Finch Therapeutics TTM CFO year-on-year change?
What is Finch Therapeutics annual cash flow from operations?
The current annual CFO of FNCH is -$31.50 M
What is the all time high annual CFO for Finch Therapeutics?
Finch Therapeutics all-time high annual cash flow from operations is -$17.32 M
What is Finch Therapeutics annual CFO year-on-year change?
Over the past year, FNCH annual cash flow from operations has changed by +$43.35 M (+57.91%)
What is Finch Therapeutics quarterly cash flow from operations?
The current quarterly CFO of FNCH is -$4.73 M
What is the all time high quarterly CFO for Finch Therapeutics?
Finch Therapeutics all-time high quarterly cash flow from operations is -$3.71 M
What is Finch Therapeutics quarterly CFO year-on-year change?
Over the past year, FNCH quarterly cash flow from operations has changed by +$535.00 K (+10.17%)
What is Finch Therapeutics TTM cash flow from operations?
The current TTM CFO of FNCH is -$18.05 M
What is the all time high TTM CFO for Finch Therapeutics?
Finch Therapeutics all-time high TTM cash flow from operations is -$5.97 M
What is Finch Therapeutics TTM CFO year-on-year change?
Over the past year, FNCH TTM cash flow from operations has changed by +$24.02 M (+57.08%)